Reports and Briefs on Oncology in Europe

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | » »|

Type Product title / description Pub Price
Report
Report

Market and Product Forecasts: Melanoma – Yervoy will continue to dominate as new approvals struggle to compete

This report and accompanying deliverable provides forecasts for melanoma drugs in the US and five major EU markets from 2012-21. Including in-depth analysis of the melanoma market in individual countries and dynamics of the key therapies.

Published By Datamonitor
23 Oct 2012 $6400
Buy
Report
Report

Market and Product Forecasts: HER2-Negative/Hormone Receptor-Positive Breast Cancer - Patent expiries and novel drugs shape the market in the next decade

This report and accompanying deliverable provides forecasts for HER2-/HR+ breast cancer drugs in the seven major markets from 2011-20. Including in-depth analysis of the market in individual countries and molecule dynamics of the key therapies.

Published By Datamonitor
19 Jul 2012 $6400
Buy
Report
Report

Market and Product Forecasts: Colon Cancer - Older drugs remain dominant as new approvals struggle in saturated market

This report and accompanying deliverable provides forecasts for colon cancer drugs in the seven major markets from 2011-20. Including in-depth analysis of the colon cancer market in individual countries and molecule dynamics of the key therapies.

Published By Datamonitor
22 Dec 2011 $6400
Buy
Report
Report

Hepatocellular cancer: Nexavar & Pipeline products

Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market

Published By Datamonitor
24 Apr 2013 $2000
Buy
Report
Report

Epidemiology: Small Cell Lung Cancer – Prognosis remains poor during forecast period

Overview of small cell lung cancer definition and a review of the epidemiologic literature. This report provides an in-depth analysis of patient populations, a 10-year incident forecast, and key patient segments across the seven major markets.

Published By Datamonitor
08 Dec 2011 $2800
Buy
Report
Report

Epidemiology: Renal Cell Cancer – Incident cases set to soar

Overview of renal cell cancer definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year incident case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
28 Mar 2011 $2800
Buy
Report
Report

Epidemiology: Prostate Cancer – Incidence and prevalence reaches new heights due to testing, risk factors, and an aging population

Overview of prostate cancer definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year incident case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
29 Mar 2011 $2800
Buy
Report
Report

Epidemiology: Ovarian Cancer – Stable or declining in younger women and increasing among older women

Overview of ovarian cancer definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, 10-year incident and prevalent case forecasts, and key patient segments across the seven major markets.

Published By Datamonitor
02 Mar 2012 $2800
Buy
Report
Report

Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to stop smoking, incidence rates will remain unchanged

Overview of non-small cell lung cancer definition and a review of the epidemiologic literature. This report provides an in-depth analysis of patient populations, a 10-year incident forecast, and key patient segments across the seven major markets.

Published By Datamonitor
21 Nov 2011 $2800
Buy
Report
Report

Epidemiology: Malignant Melanoma – Increasing by roughly 3% annually and affecting all age groups

Overview of malignant melanoma definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year incident case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
05 Apr 2012 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | » »|

No help is available.